Original Query: ALL
Previous Study | Return to List | Next Study

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00316836
Recruitment Status : Active, not recruiting
First Posted : April 21, 2006
Last Update Posted : August 8, 2017
National Cancer Institute (NCI)
NCIC Clinical Trials Group
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : October 2010
  Study Completion Date : No date given